GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » Revenue

Aarti Pharmalabs (BOM:543748) Revenue : ₹18,526 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Revenue?

Aarti Pharmalabs's revenue for the three months ended in Mar. 2024 was ₹5,058 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹18,526 Mil. Aarti Pharmalabs's Revenue per Share for the three months ended in Mar. 2024 was ₹55.81. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹204.49.

Warning Sign:

Aarti Pharmalabs Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Aarti Pharmalabs was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Aarti Pharmalabs Revenue Historical Data

The historical data trend for Aarti Pharmalabs's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Revenue Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Revenue
- 11,920.34 19,452.30 18,526.10

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,850.60 4,583.60 4,398.00 4,486.90 5,057.70

Competitive Comparison of Aarti Pharmalabs's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Pharmalabs's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's Revenue distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's Revenue falls into.



Aarti Pharmalabs Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹18,526 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Pharmalabs  (BOM:543748) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Aarti Pharmalabs Revenue Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs (BOM:543748) Business Description

Traded in Other Exchanges
Address
204, Udyog Kshetra, Mulund Goregaon Link Road, 2nd floor,, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives.

Aarti Pharmalabs (BOM:543748) Headlines

No Headlines